ALPMY
equitynet sellingAstellas Pharma Inc · TOKYO STOCK EXCHANGE-TOKYO PRO MARKET
Buy it with play money
Fills at the latest stored close and lands in your paper portfolio
Sign in to buy ALPMY with $10,000 of play money and watch it from here.
Sign in to tradePrice, and when Congress traded it
Hollow marks where they traded, filled where the filing went public
Hover a marker to see who traded and what it was worth.
If you had bought it yourself
Paid at that day's close, held ever since. No member involved.
Working it out…
Short interest
Shares sold short, as brokers report them to FINRA twice a month
| Settlement date | Shares short | Change | Days to cover |
|---|---|---|---|
| Sep 30, 2026 | 155.43K | +519.9% | 0.8 |
| Sep 15, 2026 | 25.07K | -64.5% | 0.1 |
| Aug 31, 2026 | 70.65K | +28.2% | 0.4 |
| Aug 14, 2026 | 55.09K | -22.0% | 0.4 |
| Jul 31, 2026 | 70.63K | +69.3% | 0.2 |
| Jul 15, 2026 | 41.71K | -16.5% | 0.1 |
| Jun 30, 2026 | 49.92K | +201.3% | 0.1 |
| Jun 15, 2026 | 16.57K | -37.3% | 0.0 |
Largest fails to deliver, the last year
28 settlement days with at least $10,000 of shares sold and not delivered
| Settlement date | Shares | Value |
|---|---|---|
| Jul 16, 2026 | 136.62K | $1.8M |
| Feb 12, 2026 | 107.25K | $1.8M |
| Feb 11, 2026 | 71.97K | $1.2M |
| Oct 27, 2025 | 101.36K | $1.1M |
| Apr 24, 2026 | 20K | $309.6K |
Short interest is every broker's short position at the settlement date, reported to FINRA and published about a week and a half later; it does not say who is short. Days to cover is the short position over the average day's trading, and the share of the company is against the shares outstanding on its latest filing. A fail to deliver is the balance of shares sold and not delivered by settlement, from the SEC: it can be a short seller who never borrowed the stock, but is as often a late delivery that clears within days.
What they lobby on
Disclosed to the Senate, largest spend first
- ASTELLAS PHARMA US, INC.$590K
Medicare/Medicaid, Health Issues, Copyright/Patent/Trademark, Taxation/Internal Revenue Code
1st Quarter (Jan 1 - Mar 31) 2026
- ASTELLAS PHARMA US, INC.$510K
Medicare/Medicaid, Health Issues, Copyright/Patent/Trademark, Taxation/Internal Revenue Code
2nd Quarter (Apr 1 - June 30) 2026
- TARPLIN, DOWNS & YOUNG, LLC$80K
Health Issues
2nd Quarter (Apr 1 - June 30) 2026
- TARPLIN, DOWNS & YOUNG, LLC$80K
Health Issues
2nd Quarter (Apr 1 - June 30) 2026
- TARPLIN, DOWNS & YOUNG, LLC$80K
Health Issues
1st Quarter (Jan 1 - Mar 31) 2026
- THEGROUP DC, LLC$70K
Health Issues, Pharmacy
1st Quarter (Jan 1 - Mar 31) 2026
- THEGROUP DC, LLC$70K
Health Issues, Pharmacy
2nd Quarter (Apr 1 - June 30) 2026
- TIBER CREEK GROUP$60K
Health Issues, Medicare/Medicaid
1st Quarter (Jan 1 - Mar 31) 2026
More on ALPMY
Who traded it
Most active first
| Member | Buys | Sells |
|---|---|---|
| Tom MacArthurNJ-03 · house | 2 | 2 |
| Dan GoldmanNY-10 · house | 1 | 2 |
| Greg GianforteMT-00 · house | — | 1 |
Every disclosure
8 in total, newest first
| Member | Amount |
|---|---|
| Dan GoldmanNY · housesell | $15K – $50K |
| Dan GoldmanNY · housebuy | $15K – $50K |
| Dan GoldmanNY · housesell | $1K – $15K |
| Greg GianforteMT · houseselljoint | $1K – $15K |
| Tom MacArthurNJ · houseselljoint | $15K – $50K |
| Tom MacArthurNJ · housebuyjoint | $1K – $15K |
| Tom MacArthurNJ · housebuyjoint | $15K – $50K |
| Tom MacArthurNJ · houseselljoint | $15K – $50K |
Follow Astellas Pharma Inc (ALPMY) by email
New trades in Astellas Pharma Inc (ALPMY) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.